Clinical Trial Update: Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study [Phase 2]

View source ↗

Summary

A single-arm Phase II trial in advanced Hodgkin lymphoma evaluating a very early PET-response-guided targeted therapy; results have been posted and the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Advanced Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-08-11